Slashdot

Syndicate content Slashdot
News for nerds, stuff that matters
Updated: 6 min 14 sec ago

BBC Takes a Stand For the Public's Right To Remember Redacted Links

Sun, 19/10/2014 - 9:21am
Martin Spamer writes with word that the BBC is to publish a continually updated list of its articles removed from Google under the controversial 'right to be forgotten' notices." The BBC will begin - in the "next few weeks" - publishing the list of removed URLs it has been notified about by Google. [Editorial policy head David] Jordan said the BBC had so far been notified of 46 links to articles that had been removed. They included a link to a blog post by Economics Editor Robert Peston. The request was believed to have been made by a person who had left a comment underneath the article. An EU spokesman later said the removal was "not a good judgement" by Google.

Read more of this story at Slashdot.








BBC Takes a Stand For the Public's Right To Remember Redacted Links

Sun, 19/10/2014 - 9:21am
Martin Spamer writes with word that the BBC is to publish a continually updated list of its articles removed from Google under the controversial 'right to be forgotten' notices." The BBC will begin - in the "next few weeks" - publishing the list of removed URLs it has been notified about by Google. [Editorial policy head David] Jordan said the BBC had so far been notified of 46 links to articles that had been removed. They included a link to a blog post by Economics Editor Robert Peston. The request was believed to have been made by a person who had left a comment underneath the article. An EU spokesman later said the removal was "not a good judgement" by Google.

Read more of this story at Slashdot.








BBC Takes a Stand For the Public's Right To Remember Redacted Links

Sun, 19/10/2014 - 9:21am
Martin Spamer writes with word that the BBC is to publish a continually updated list of its articles removed from Google under the controversial 'right to be forgotten' notices." The BBC will begin - in the "next few weeks" - publishing the list of removed URLs it has been notified about by Google. [Editorial policy head David] Jordan said the BBC had so far been notified of 46 links to articles that had been removed. They included a link to a blog post by Economics Editor Robert Peston. The request was believed to have been made by a person who had left a comment underneath the article. An EU spokesman later said the removal was "not a good judgement" by Google.

Read more of this story at Slashdot.








BBC Takes a Stand For the Public's Right To Remember Redacted Links

Sun, 19/10/2014 - 9:21am
Martin Spamer writes with word that the BBC is to publish a continually updated list of its articles removed from Google under the controversial 'right to be forgotten' notices." The BBC will begin - in the "next few weeks" - publishing the list of removed URLs it has been notified about by Google. [Editorial policy head David] Jordan said the BBC had so far been notified of 46 links to articles that had been removed. They included a link to a blog post by Economics Editor Robert Peston. The request was believed to have been made by a person who had left a comment underneath the article. An EU spokesman later said the removal was "not a good judgement" by Google.

Read more of this story at Slashdot.








BBC Takes a Stand For the Public's Right To Remember Redacted Links

Sun, 19/10/2014 - 9:21am
Martin Spamer writes with word that the BBC is to publish a continually updated list of its articles removed from Google under the controversial 'right to be forgotten' notices." The BBC will begin - in the "next few weeks" - publishing the list of removed URLs it has been notified about by Google. [Editorial policy head David] Jordan said the BBC had so far been notified of 46 links to articles that had been removed. They included a link to a blog post by Economics Editor Robert Peston. The request was believed to have been made by a person who had left a comment underneath the article. An EU spokesman later said the removal was "not a good judgement" by Google.

Read more of this story at Slashdot.








BBC Takes a Stand For the Public's Right To Remember Redacted Links

Sun, 19/10/2014 - 9:21am
Martin Spamer writes with word that the BBC is to publish a continually updated list of its articles removed from Google under the controversial 'right to be forgotten' notices." The BBC will begin - in the "next few weeks" - publishing the list of removed URLs it has been notified about by Google. [Editorial policy head David] Jordan said the BBC had so far been notified of 46 links to articles that had been removed. They included a link to a blog post by Economics Editor Robert Peston. The request was believed to have been made by a person who had left a comment underneath the article. An EU spokesman later said the removal was "not a good judgement" by Google.

Read more of this story at Slashdot.








BBC Takes a Stand For the Public's Right To Remember Redacted Links

Sun, 19/10/2014 - 9:21am
Martin Spamer writes with word that the BBC is to publish a continually updated list of its articles removed from Google under the controversial 'right to be forgotten' notices." The BBC will begin - in the "next few weeks" - publishing the list of removed URLs it has been notified about by Google. [Editorial policy head David] Jordan said the BBC had so far been notified of 46 links to articles that had been removed. They included a link to a blog post by Economics Editor Robert Peston. The request was believed to have been made by a person who had left a comment underneath the article. An EU spokesman later said the removal was "not a good judgement" by Google.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 19/10/2014 - 6:15am
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 19/10/2014 - 6:15am
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 19/10/2014 - 6:15am
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 19/10/2014 - 6:15am
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 19/10/2014 - 6:15am
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 19/10/2014 - 6:15am
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 19/10/2014 - 6:15am
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 19/10/2014 - 6:15am
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 19/10/2014 - 6:15am
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 19/10/2014 - 6:15am
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 19/10/2014 - 6:15am
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 19/10/2014 - 6:15am
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.








Canada Will Ship 800 Doses of Experimental Ebola Drug to WHO

Sun, 19/10/2014 - 6:15am
The WSJ reports that 800 doses of an experimental vaccine for Ebola, developed over a decade at Public Health Agency of Canada’s main laboratory in Winnipeg, will be shipped to the World Health Organization in an effort to help fight the ongoing Ebola crisis in West Africa: The vaccine will be shipped by air from Winnipeg, Manitoba, to the University Hospital of Geneva via specialized courier. The vials will be sent in three separate shipments as a precautionary measure, due to the challenges in moving a vaccine that must kept at a very low temperature at all times. ... The vaccine had shown “very promising results in animal research” and earlier this week, Ottawa announced the start of clinical trials on humans at the Walter Reed Army Institute of Research in the U.S. ... The government has licensed NewLink Genetics Corp. , of the U.S., through its wholly owned subsidiary BioProtection Systems Corp. to further develop the vaccine for use in humans. The government owns the intellectual property rights associated with the vaccine.

Read more of this story at Slashdot.